β-trace protein: From GFR marker to cardiovascular risk predictor

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 5, 2013, Pages 873-881

  Orenes Piñero, Esteban ^a   Manzano Fernández, Sergio ^a   López Cuenca, Ángel ^a   Marín, Francisco ^a   Valdés, Mariano ^a   Januzzi, James L ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; CYCLOOXYGENASE 2; CYSTATIN C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; BIOLOGICAL MARKER; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

ACUTE CORONARY SYNDROME; ALBUMINURIA; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HYPERTENSION; ISCHEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY INJURY; LIQUORRHEA; REVIEW; ANIMAL; CARDIOVASCULAR DISEASES; HUMAN; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY; KIDNEY DISEASES; LIPOCALINS; RISK ASSESSMENT; RISK FACTORS;

EID: 84877671524     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08870812     Document Type: Review

References (54)

1. Urade Y, Hayaishi O: Prostaglandin D synthase: Structure and function. Vitam Horm 58: 89-120, 2000
2. Kanaoka Y, Ago H, Inagaki E, Nanayama T, Miyano M, Kikuno R, Fujii Y, Eguchi N, Toh H, Urade Y, Hayaishi O: Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 90: 1085-1095, 1997
3. Urade Y, Nagata A, Suzuki Y, Fujii Y, Hayaishi O: Primary structure of rat brain prostaglandin D synthetase deduced from cDNA sequence. J Biol Chem 264: 1041-1045, 1989
4. Han F, Takeda K, Ishikawa K, Ono M, Date F, Yokoyama S, Furuyama K, Shinozawa Y, Urade Y, Shibahara S: Induction of lipocalin-type prostaglandin D synthase in mouse heart under hypoxemia. BiochemBiophys Res Commun 385:449-453,2009
5. Eguchi Y, Eguchi N, Oda H, Seiki K, Kijima Y, Matsu-ura Y, Urade Y, Hayaishi O: Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94: 14689-14694, 1997
6. Nagata N, Fujimori K, Okazaki I, Oda H, Eguchi N, Uehara Y, Urade Y: De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneys. FEBS J 276: 7146-7158, 2009
7. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S: Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017, 2000
8. Beuckmann CT, Aoyagi M, Okazaki I, Hiroike T, Toh H, Hayaishi O, Urade Y: Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry 38: 8006-8013, 1999
9. Pöge U, Gerhardt TM, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP: β-Trace protein is an alternative marker for glomerular filtration ratein renal transplantationpatients. Clin Chem 51: 1531-1533, 2005
10. Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Hayashida K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K: Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest 119: 1477-1488, 2009
11. Tanaka R, Miwa Y, Mou K, Tomikawa M, Eguchi N, Urade Y, Takahashi-Yanaga F, Morimoto S, Wake N, Sasaguri T: Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun 378: 851-856, 2009
12. Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, Mezzetti A: Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265, 2004
13. Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, Ozaki Y, Waseda K, Oda H, Seiki K, Node K, Urade Y: Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 201: 385-391, 2008
14. Hirawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S: Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 39: 449-454, 2002
15. Manzano-Fernández S, Januzzi JL, Boronat-Garcia M, Bonaque-González JC, Truong QA, Pastor-Pérez FJ, Muñoz-Esparza C, Pastor P, Albaladejo-Otón MD, Casas T, Valdés M, Pascual-Figal DA: b-trace protein and cystatin C as predictors of long-term outcomes in patientswith acute heart failure. JAmColl Cardiol 57: 849-858, 2011
16. Matsumoto T, Eguchi Y, Oda H, Yamane T, Tarutani Y, Ozawa T, Hayashi H, Nakae I, Horie M, Urade Y: Lipocalin-type prosta-glandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine. Circ J 75: 897-904, 2011
17. Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F: Usefulness of b-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes. Am J Cardiol 110: 1240-1248, 2012
18. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: 167-184, 1990
19. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[2 SUPPL. 1]: S1-S266, 2002
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
22. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS: Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 18: 2749-2757, 2007
23. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
24. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
25. Pöge U, Gerhardt T, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP: Beta-trace protein-based equations for calculation of GFR in renal transplant recipients. Am J Transplant 8: 608-615, 2008
26. Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group: Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 58: 886-893, 2011
27. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J: Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 59: 653-662, 2012
28. Bataille R, Durie BG, Grenier J: Serum β2 microglobulin and survival duration in multiple myeloma: A simple reliable marker for staging. Br J Haematol 55: 439-447, 1983
29. Chen HH: β-trace protein versus cystatin C: Which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases? J Am Coll Cardiol 57: 859-860, 2011
30. Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J: Serum b-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol 7: 1435-1445, 2012
31. Woitas RP, Stoffel-Wagner B, Poege U, Schiedermaier P, Spengler U, Sauerbruch T: Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem 47: 2179-2180, 2001
32. Priem F, Althaus H, Jung K, Sinha P: Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate. Clin Chem 47: 2181, 2001
33. Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, Keely E, Matzinger M, Akbari A, Althaus H, Jung K: Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 48: 729-736, 2002
34. Spanaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A; Mild and Moderate Kidney Disease (MMKD) StudyGroup: Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem 56: 740-749, 2010
35. Risch L, Herklotz R, Blumberg A, Huber AR: Effects of gluco-corticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47: 2055-2059, 2001
36. Risch L, Saely C, Reist U, Reist K, Hefti M, Huber AR: Course of glomerular filtration rate markers in patients receiving high-dose glucocorticoids following subarachnoidal hemorrhage. Clin Chim Acta 360: 205-207, 2005
37. Uehara Y, Makino H, Seiki K, Urade Y; L-PGDS Clinical Research Group of Kidney: Urinary excretions of lipocalin-type prosta-glandin D synthase predict renal injury in type-2 diabetes: A cross-sectional and prospective multicentre study. Nephrol Dial Transplant 24: 475-482, 2009
38. Yoshikawa R, Wada J, Seiki K, Matsuoka T, Miyamoto S, Takahashi K, Ota S, Taniai K, Hida K, Yamakado M, Shikata K, Uehara Y, Urade Y, Makino H: Urinary PGDS levels are associated with vascular injury intype 2diabetespatients. Diabetes Res Clin Pract 76: 358-367, 2007
39. Ogawa M, Hirawa N, Tsuchida T, Eguchi N, Kawabata Y, Numabe A, Negoro H, Hakamada-Taguchi R, Seiki K, Umemura S, Urade Y, Uehara Y: Urinary excretions of lipocalin-type prosta-glandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats. Nephrol Dial Transplant 21: 924-934, 2006
40. Dajak M, Ignjatovic S, Stojimirovic B, Gajic S, Majkic-Singh N: Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease. Clin ChimActa 411: 1154-1155, 2010
41. Donadio C: Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: Diagnostic accuracy of urinary/3-trace protein. AmJ Physiol Renal Physio l299: F1407-F1423, 2010
42. Taba Y, Sasaguri T, Miyagi M, Abumiya T, Miwa Y, Ikeda T, Mitsumata M: Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. Circ Res 86: 967-973, 2000
43. Negoro H, SooShin W, Hakamada-Taguchi R, Eguchi N, Urade Y, Goto A, Toyo-Oka T, Fujita T, Omata M, Uehara Y: Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. J Hypertens 20: 1347-1354, 2002
44. Miwa Y, Takiuchi S, Kamide K, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Sasaguri T, Kawano Y: Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients. Biochem Biophys Res Commun 322: 428-433, 2004
45. Taba Y, Miyagi M, Miwa Y, Inoue H, Takahashi-Yanaga F, Morimoto S, Sasaguri T: 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells. AmJ Physiol Heart Circ Physiol 285: H38-H46, 2003
46. Negoro H, Shin WS, Hakamada-Taguchi R, Eguchi N, Urade Y, Goto A, Toyo-Oka T, Fujita T, Omata M, Uehara Y: Endogenous prostaglandin D(2) synthesis decreases vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. Life Sci 78: 22-29, 2005
47. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998
48. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG: Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108, 2000
49. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD: Ubiquitin protein ligase activity of IAPs and their degradation in protea-somes in response to apoptotic stimuli. Science 288: 874-877, 2000
50. 12,14-prostaglandin J2. J Biol Chem 274: 17042-17048, 1999
51. Levonen AL, Dickinson DA, Moellering DR, Mulcahy RT, Forman HJ, Darley-Usmar VM: Biphasic effects of 15-deoxy-delta (12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol 21: 1846-1851, 2001
52. Segal J, Kern MJ, Scott NA, King SB, Doucette JW, Heuser RR, Ofili E, Siegel R: Alterations of phasic coronary artery flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol 20: 276-286, 1992
53. Inoue T, Takayanagi K, Morooka S, Uehara Y, Oda H, Seiki K, Nakajima H, Urade Y: Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 85: 165-170, 2001
54. Ando J, Yamamoto K: Vascular mechanobiology: Endothelial cell responses to fluid shear stress. CircJ 73: 1983-1992, 2009